Archive: 14/08/2017
Virulence factor made by influenza virus is potential target for vaccine drug development
A new study describes how NS1, a protein produced by influenza A viruses, suppresses the body's immune responses to viral infection. Researchers present the potential to develop a live attenuated vaccine based on an engineered ...
Aug 14, 2017